Cleared Traditional

K900072 - IMMUNODOT AUTOIMMUNITY SCREENING PANEL 2

K900072 is an FDA 510(k) clearance for IMMUNODOT AUTOIMMUNITY SCREENING PANEL 2, manufactured by General Biometrics, Inc.. The device is a Class 2 Immunology device with product code LJM cleared through the Traditional 510(k) pathway after a 19-day FDA review.

K900072 · General Biometrics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
19d
Days
Class 2
Risk

K900072 is an FDA 510(k) clearance for the IMMUNODOT AUTOIMMUNITY SCREENING PANEL 2. Classified as Antinuclear Antibody (enzyme-labeled), Antigen, Controls (product code LJM), Class II - Special Controls.

Submitted by General Biometrics, Inc. (San Diego, US). The FDA issued a Cleared decision on January 24, 1990 after a review of 19 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all General Biometrics, Inc. devices

FDA 510(k) Submission Details - K900072

510(k) Number K900072 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 1990
Decision Date January 24, 1990
Days to Decision 19 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 104d · This submission: 19d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJM Device Classification - Class 2, Special Controls

Product Code LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls

All 58
Devices cleared under the same product code (LJM) and FDA review panel - the closest regulatory comparables to K900072.
HEMAGEN ENA [RNP/SM] KIT (EIA METHOD)
K915272 · Hemagen Diagnostics, Inc. · Mar 1992
DIASTAT ENA PROFILE
K905190 · Shield Diagnostics, Ltd. · Dec 1990
ANTI-SCI-70 MICROASSAY
K902915 · Diamedix Corp. · Sep 1990
IMMUNODOT AUTOIMMUNE SCREENING PANEL 1
K896347 · General Biometrics, Inc. · Dec 1989
ANTI-SM MICROASSAY
K894894 · Diamedix Corp. · Aug 1989
DNA STAT TEST KIT
K843904 · Whittaker Bioproducts, Inc. · Nov 1984